LIVESTRONG Exercise Program Improves QoL in Cancer Survivors

LIVESTRONG Exercise Program Improves QoL in Cancer Survivors

The LIVESTRONG at the YMCA exercise program significantly improved physical activity, fitness, and quality of life in survivors of cancer.

AYA Cancer Survivors More Likely to Have Mental Distress Than Healthy Individuals

AYA Cancer Survivors More Likely to Have Mental Distress Than Healthy Individuals

Using the Kessler nonspecific mental/psychological distress scale, investigators examined whether AYA cancer survivor experienced greater mental distress and assessed their access to mental health care.

Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

Loss of bone density related to chemotherapy and adjuvant therapy for breast cancer can lead to debilitating hip and vertebral fractures. This discussion discusses the impact of resistance training for these patients.

Cancer Patients Benefit From Exercise Both During and After Treatment

Cancer Patients Benefit From Exercise Both During and After Treatment

Studies show better physical function and quality of life for cancer patients who do strength training or aerobic activity.

Study Identifies Factors Associated With Platinum-induced Ototoxicity in Pediatric Cancer Survivors

Large cohort study assesses the frequency of, and factors associated with, ototoxicity in childhood cancer survivors who received platinum agents without cranial irradiation.

Long-Term Health Not Improved for Childhood Cancer Survivors

Long-Term Health Not Improved for Childhood Cancer Survivors

Research shows only modest improvements in the physical or mental health of childhood cancer survivors in recent decades.

Making End of Life Discussions Easier on Patients and Caregivers

Making End of Life Discussions Easier on Patients and Caregivers

A new card game helps patients and caregivers broach the difficult subject of end-of-life wishes and prioritize what's most important in their planning.

Telerehabilitation Program Improves Posttreatment Effects in Breast Cancer Survivors

Telerehabilitation Program Improves Posttreatment Effects in Breast Cancer Survivors

Study evaluates whether a web-based rehabilitation program can effectively improve pain, fatigue, strength, and quality of life for breast cancer survivors.

An App for Intubated Cancer Patients: Giving Voice to the Voiceless

An App for Intubated Cancer Patients: Giving Voice to the Voiceless

A nurse develops a tablet app that helps intubated patients communicate with their nurses, caregivers, and families.

Cancer Survivors Display Higher Rate of Antidepressant Use

Cancer Survivors Display Higher Rate of Antidepressant Use

Nearly one in five cancer survivors are taking medication for depression or anxiety years later.

Side of Origin Affects Colon Cancer Survival

Side of Origin Affects Colon Cancer Survival

Researchers observed a significant disparity in colon cancer mortality related to origin location, independent of confounding variables.

Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors

Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors

In this study, researchers assessed data on women who underwent breast cancer treatment to identify the factors associated with posttreatment imaging use.

Childhood Cancer Linked to Poor Diet Quality in Adult Survivors

Childhood Cancer Linked to Poor Diet Quality in Adult Survivors

Epidemiologic study reveals the impact of cancer and its treatment on diet quality among adult survivors of childhood cancers.

Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors

Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors

Researchers examined the long-term effects of a short-term culturally based dietary intervention on increasing the consumption of fruits and vegetables, decreasing fat, and changing biomarkers associated with recurrence in Hispanic breast cancer survivors.

How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians

How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians

Cancers that cause more readily noticeable physical changes can produce self-image challenges for patients. This discussion reviews what interventions can help validate patients' self-image concerns.

CDK4/6 Inhibitor Plus Aromatase Inhibitor Improves Progression-Free Survival in Metastatic Breast Cancer

CDK4/6 Inhibitor Plus Aromatase Inhibitor Improves Progression-Free Survival in Metastatic Breast Cancer

Adding ribociclib to letrozole significantly improves progression-free survival for postmenopausal women with metastatic hormone receptor (HR)-positive breast cancer, compared with hormone therapy alone.

Internalizing, Externalizing Behavioral Problems a Significant Postdiagnosis Concern in Children With Cancer

Internalizing, Externalizing Behavioral Problems a Significant Postdiagnosis Concern in Children With Cancer

Children with cancer are at risk for developing behavioral problems after diagnosis.

U.S. Health Care System Ranks Among Least Efficient Worldwide

U.S. Health Care System Ranks Among Least Efficient Worldwide

The United States has remained near the bottom of the Bloomberg Health-Care Efficiency Index since its creation in 2012.

Daratumumab With Len-Dex Prolongs PFS in R/R Multiple Myeloma

Daratumumab With Len-Dex Prolongs PFS in R/R Multiple Myeloma

Adding daratumumab to lenalidomide and dexamethasone significantly prolonged progression-free survival compared with lenalidomide plus dexamethasone alone in patients with relapsed or refractory multiple myeloma.

Severe Fatigue Associated With Unemployment in Hodgkin Lymphoma Survivors

Severe Fatigue Associated With Unemployment in Hodgkin Lymphoma Survivors

Severe fatigue is associated with unemployment and financial problems in survivors of Hodgkin lymphoma, highlighting the need for clinicians to address fatigue in these patients.

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

Patients with oropharyngeal tumors that harbor HPV16 have higher 5-year survival and lower recurrence rates than patients with tumors that harbor other HPV strains or are HPV-negative.

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

Postdiagnosis Physical Activity Linked to Improved Physical QoL in Prostate Cancer Survivors

Prostate cancer survivors who maintain or begin recreational physical activity following cancer diagnosis report substantially higher quality of life than those who never exercise or stopped exercising after diagnosis.

HRQoL Better Maintained With Pembrolizumab in Ipilimumab-refractory Melanoma

HRQoL Better Maintained With Pembrolizumab in Ipilimumab-refractory Melanoma

Treatment with pembrolizumab better maintained health-related quality of life compared with chemotherapy in patients with advanced melanoma refractory to ipilimumab.

SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC

Continued adoption of stereotactic body radiation therapy (SBRT) to treat early stage NSCLC improved OS and lung cancer-specific survival, according to a study presented at the 2016 annual meeting of the American Society for Radiation Oncology.

Adding Bevacizumab to Adjuvant Capecitabine Not Effective for mCRC

The combination of adjuvant bevacizumab and capecitabine failed to improve disease-free survival compared with capecitabine alone in patients with mCRC who had undergone potentially curative surgery.

Cancer Mortality Decrease Observed for Children and Adolescents

Cancer Mortality Decrease Observed for Children and Adolescents

A twenty percent decrease in cancer death rate among children and adolescents has taken place from 1999 to 2014.

MRD Negativity Associated With Prolonged Survival in Myeloma

MRD Negativity Associated With Prolonged Survival in Myeloma

Minimal residual disease (MRD) negativity after treatment is associated with prolonged overall survival in patients with newly diagnosed multiple myeloma.

Analysis of Population Trends Shows Use of Electronic Cigarettes Increase Quit Success

Analysis of Population Trends Shows Use of Electronic Cigarettes Increase Quit Success

An analysis of population trends in England demonstrated that use of electronic cigarettes improves the rate of successful quit attempts, but results in less use of prescription nicotine-replacement therapy products.

Early Palliative Care Improves Quality of Life for Terminal Cancer Patients

Early Palliative Care Improves Quality of Life for Terminal Cancer Patients

Early care after an incurable cancer diagnosis improves quality of life and also increases the chances of having end-of-life discussions.

Inpatient Palliative Care Improves QoL for Patients Hospitalized for HCT

Inpatient Palliative Care Improves QoL for Patients Hospitalized for HCT

Palliative care improved quality of life, depression, anxiety, and symptom burden in patients with hematologic malignancies hospitalized for hematopoietic stem cell transplantation (HCT).

Smartphone Apps Help Patients Reach Health and Fitness Goals

Smartphone Apps Help Patients Reach Health and Fitness Goals

Smartphones can motivate patients to stay on track with lifestyle changes.

Immune Cells Are Biologically Older After Hematopoietic Cell Transplantation

Immune Cells Are Biologically Older After Hematopoietic Cell Transplantation

Hematopoietic stem cell transplantation (HCT) is found to increase expression of a genetic code used to make proteins, leading to a biological aging of immune cells equivalent to 30 years of chronological age.

Outcomes in Patients With Brain Metastasis from Esophageal Carcinoma

Outcomes in Patients With Brain Metastasis from Esophageal Carcinoma

[Journal of Gastrointestinal Oncology] This research examines factors associated with survival in patients with brain metastasis from esophageal cancer.

EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments

EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments

The population-based EUTOS registry demonstrated high overall and progression-free survival rates among patients with chronic myeloid leukemia.

HIV Infection Worsens Survival of Patients With Cervical Cancer

HIV Infection Worsens Survival of Patients With Cervical Cancer

HIV is associated with reduced cancer-specific survival among women with invasive cervical cancer.

African American Breast Cancer Survivors Report Significant Problem Burden

African American Breast Cancer Survivors Report Significant Problem Burden

African American survivors of breast cancer experience significant problem burden during the first 5 years after diagnosis and treatment.

Increasing Dietary Omega-3 Intake After Colorectal Cancer Diagnosis Improves Survival

Increasing Dietary Omega-3 Intake After Colorectal Cancer Diagnosis Improves Survival

Lifestyle and dietary measures for preventing colorectal cancer are extensively studied; however, in this study, researchers looked at a dietary measure that improved survival for patients after diagnosis.

Clinician Answers on Safety of E-Cigarettes Vary

Clinician Answers on Safety of E-Cigarettes Vary

When patients ask about safety and using e-cigarettes to stop smoking, doctors give varying advice.

Risk for Adverse Pulmonary Events Higher in Adult Survivors of Childhood Cancer

Risk for Adverse Pulmonary Events Higher in Adult Survivors of Childhood Cancer

Adult survivors of childhood cancer are at increased risk for late adverse pulmonary events.

Study Identifies Disparities in Cancer Pain Management

Study Identifies Disparities in Cancer Pain Management

Cancer survivors who are nonwhite, less educated, older, and/or have comorbidities were less likely to receive adequate cancer pain management.

Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinoma

Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinoma

[OncoTargets and Therapy] This research reviews the effects of single-port access transaxillary totally endoscopic thyroidectomy on outcomes following surgery, including quality of life and cosmetic result, in patients with papillary thyroid carcinoma (PTC).

Sexual Dissatisfaction Prevalent Among Cancer Survivors, Especially in Women

Sexual Dissatisfaction Prevalent Among Cancer Survivors, Especially in Women

Older cancer survivors' self-reports of sexual activity and functioning are comparable to age-matched people without cancer; despite this, sexual dissatisfaction is more prevalent among cancer survivors than age-matched cancer-free persons.

Addition of Elotuzumab to Bortezomib/Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma

Addition of Elotuzumab to Bortezomib/Dexamethasone Improves Survival in Relapsed/Refractory Multiple Myeloma

The addition of elotuzumab to bortezomib/dexamethasone appears to increase progression-free survival in relapsed/refractory multiple myeloma (RRMM).

Survivors Diagnosed at Young Age More Likely to be Financially Dependent

Survivors Diagnosed at Young Age More Likely to be Financially Dependent

Younger cancer survivors in Norway were more likely to be financially dependent and unemployed than individuals without cancer.

In NSCLC, Erlotinib Appears Effective at Doses Lower Than MTD

In NSCLC, Erlotinib Appears Effective at Doses Lower Than MTD

Patients with metastatic non-small cell lung cancer demonstrated prolonged median progression-free survival with the administration of erlotinib below the maximum tolerated dose.

Metformin Use May Improve Survival in Patients With CRC, Diabetes

Research indicates that metformin can confer improved survival for patients with colorectal cancer that also have diabetes.

Adding Daratumumab to Lenalidomide/Dexamethasone Improves Survival in Multiple Myeloma

Adding Daratumumab to Lenalidomide/Dexamethasone Improves Survival in Multiple Myeloma

Treatment with daratumumab, lenalidomide, and dexamethasone (DRd) may be superior to lenalidomide and dexamethasone (Rd) alone in patients with relapsed or refractory multiple myeloma.

CML-CP: Dasatinib, Nilotinib Associated With Similar Survival Outcomes as Frontline Therapy

CML-CP: Dasatinib, Nilotinib Associated With Similar Survival Outcomes as Frontline Therapy

Dasatinib and nilotinib are associated with similar response rates and survival outcomes in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP).

Medicaid Insurance Linked to Worse Outcomes for Patients With Glioblastoma Multiforme

Medicaid Insurance Linked to Worse Outcomes for Patients With Glioblastoma Multiforme

Insurance status influences overall patient survival for some cancer types, but its impact on glioblastoma multiforme (GBM) survival is well documented. This research study explored the possible impact of insurance on GBM survival.

ADT May Reduce Survival in African American Men With Favorable-risk Prostate Cancer

ADT May Reduce Survival in African American Men With Favorable-risk Prostate Cancer

Use of androgen suppression therapy may negatively impact survival in African American patients with favorable-risk prostate cancer.

Age-Related Prognosis in Breast Cancer Varies by Subtype

Age-Related Prognosis in Breast Cancer Varies by Subtype

Survival among women age 40 years and younger with breast cancer appears to vary according to breast cancer subtype, with age particularly prognostic for women with luminal type breast cancers.

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.

Salvage Radiotherapy at Lower PSA Levels May be Beneficial

Salvage Radiotherapy at Lower PSA Levels May be Beneficial

As salvage radiotherapy (SRT) outcomes may be affected by factors associated with prostatectomy findings, they may be positively affected when used at lower prostate-specific antigen (PSA) levels.

Acupressure Improves Fatigue, Sleep, and Quality of Life for Survivors of Breast Cancer

Acupressure Improves Fatigue, Sleep, and Quality of Life for Survivors of Breast Cancer

Acupressure reduced persistent fatigue in women who had been treated for breast cancer, improving both sleep and quality of life.

Quality of Life Not Affected by Active Surveillance of Prostate Cancer

Quality of Life Not Affected by Active Surveillance of Prostate Cancer

Choosing no treatment and regular check-ups didn't seem to stress men with low-risk disease

Fitness Nearly as Important as Not Smoking for Longevity

Fitness Nearly as Important as Not Smoking for Longevity

Low aerobic capacity has greater effect on longevity than even high cholesterol, or high blood pressure.

Tyrosine Kinase Inhibitor Therapy Can Be Safely Stopped in Select Patients With CML in Chronic Phase

Tyrosine Kinase Inhibitor Therapy Can Be Safely Stopped in Select Patients With CML in Chronic Phase

A high percentage of patients with CML treated with TKIs achieve deep molecular responses and can safely stop therapy. Initials results of the EURO-SKI trial define prognostic markers that indicate durability of deep molecular responses after stopping TKI therapy.

Systematic Palliative Care Provides Greater Improvement in Quality of Life for Patients with Pancreatic Cancer

Systematic Palliative Care Provides Greater Improvement in Quality of Life for Patients with Pancreatic Cancer

Quality of life is significantly improved for patients with pancreatic cancer when systematic palliative care is administered vs on-demand palliative care.

Adjuvant Therapy Improves Survival in Stage II Colon Cancer, Study Confirms

A very large retrospective study of patients with stage II colon cancer found adjuvant therapy improves survival, regardless of treatment regimen, patient age, or high-risk pathologic risk features.

Comprehensive Mental Health Screening Recommended for Some Childhood Cancer Survivors

Comprehensive Mental Health Screening Recommended for Some Childhood Cancer Survivors

Although most adolescent survivors of childhood cancer have no reported psychological symptoms, those who do often have multiple symptoms and distinct symptom profiles.

Telomere Length Predicts Risk for Delayed Recovery in Pediatric Patients With AML

Telomere Length Predicts Risk for Delayed Recovery in Pediatric Patients With AML

Telomere length is predictive for determining which children treated for AML are at highest risk for delayed recovery, a finding that may have significant implications for treatment-related morbidity and mortality.

Increasing Numbers of Older Cancer Survivors Challenge Clinical Trial Participant Criteria

Improved cancer detection and advances in treatment mean larger numbers of older cancer patients are becoming survivors, combined with demographic trends. But older patients are underrepresented in clinical trials.

Nivolumab Maintains Baseline HRQoL in Advanced Melanoma

Nivolumab Maintains Baseline HRQoL in Advanced Melanoma

In addition to improving overall survival compared with dacarbazine in patients with advanced melanoma, nivolumab maintains baseline levels of health-related quality of life to ultimately confer long-term quality of survival benefit.

Unrealistic Patient Expectations Top Barrier to Quality EOL Care

Unrealistic Patient Expectations Top Barrier to Quality EOL Care

In a large cohort of hematologic oncologists surveyed in the United States, standard end-of-life quality measures were highly acceptable, but unrealistic patient expectations are the greatest impediment to quality end-of-life care.

Moderate-to-Vigorous Exercise Improves Subjective Memory in Breast Cancer Survivors

Moderate-to-Vigorous Exercise Improves Subjective Memory in Breast Cancer Survivors

Memory problems in breast cancer survivors appear associated with the high stress load these patients experience rather than their treatment, and moderate-to-vigorous physical activity may help subjective memory in these patients.

Nonsolid Nodules Unlikely to Cause Death in Lung Cancer

Nonsolid Nodules Unlikely to Cause Death in Lung Cancer

Lung cancers that manifest as nonsolid nodules seem to have indolent course, according to recent research data.

Among Survivors, Relaxing Acupressure Improves Fatigue, Sleep Quality, QoL

Among Survivors, Relaxing Acupressure Improves Fatigue, Sleep Quality, QoL

Relaxing acupressure resulted in significant improvement in persistent fatigue, sleep quality, and quality of life among survivors of breast cancer, a recent study has shown.

POSTCARE Intervention May Improve QoL Among Cancer Survivors

POSTCARE Intervention May Improve QoL Among Cancer Survivors

The Patient-Owned Survivorship Transition Care for Activated, Empowered survivors (POSTCARE) intervention resulted in clinically meaningful improvements in 3 domains of quality of life (QoL) among survivors of breast cancers.

Surgery and Adjuvant Hormonal Therapy Less Effective for Older Patients With Breast Cancer

Surgery and Adjuvant Hormonal Therapy Less Effective for Older Patients With Breast Cancer

A group of researchers sought to examine the physical functioning of patients with breast cancer, in various age brackets, who were enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) phase III trial.

U.S. Cancer Survivors Aging, Battling Other Chronic Conditions

U.S. Cancer Survivors Aging, Battling Other Chronic Conditions

Likelihood of other chronic conditions will stress health care system in next two decades, as more patients with cancer live longer.

Nearly 1 in 12 Patients With a Common Cancer Develops a Second Cancer

Nearly 1 in 12 Patients With a Common Cancer Develops a Second Cancer

Nearly 1 in 12 patients with a cancer from the 10 most common cancer sites developed a second primary neoplasm during survivorship.

Many Older Women With Early Stage Breast Cancer Are Susceptible to Functional Decline After Starting Treatment

Approximately 20% of older women with stage I-III breast cancer lost the ability to complete some basic tasks of independent living within 1 year of starting treatment. However, an assessment tool can identify those women at greatest risk of posttreatment functional decline.

Extent of Resection Influences Length of Progression-Free Survival in Glioblastoma

Extent of Resection Influences Length of Progression-Free Survival in Glioblastoma

Gross total resection to treat glioblastoma multiforme (GBM) showed progression-free survival benefits over subtotal resection and biopsy in a meta-analysis of 37 studies.

Autologous Stem Cell Transplant Safe as Standard of Care in Patients With HIV-Associated Lymphoma

Autologous Stem Cell Transplant Safe as Standard of Care in Patients With HIV-Associated Lymphoma

Recent results from a multicenter, phase 2 trial suggest that patients with HIV and aggressive lymphoma should receive autologous stem cell transplant as standard of care. Risk of serious complications after transplant in these patients is equal to that of patients without HIV.

Surgery Improves Quality of Life for Patients With Malignant Pleural Mesothelioma

Surgery Improves Quality of Life for Patients With Malignant Pleural Mesothelioma

Undergoing pleurectomy and decortication for malignant pleural mesothelioma generally leads to improved quality of life after the surgery.

Type of End-of-Life Care Received Varies Based on Type of Disease

Type of End-of-Life Care Received Varies Based on Type of Disease

Cancer and dementia patients get more access to palliative care than do patients with many other chronic conditions, recent research indicates.

Overall Survival and Progression-Free Survival Are Improved With Ibrutinib for del17p CLL

Overall Survival and Progression-Free Survival Are Improved With Ibrutinib for del17p CLL

Ibrutinib treatment for chronic lymphocytic leukemia with the deletion of chromosome 17p (del17p CLL) increases the percentage of patients alive at 30 months over other therapies for del17p CLL.

Novel Antibody-Drug Conjugate Bridges Patients With Relapsed ALL to Stem Cell Transplant

Novel Antibody-Drug Conjugate Bridges Patients With Relapsed ALL to Stem Cell Transplant

In a randomized phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with ALL whose disease had relapsed following standard therapies, qualified for stem cell transplants after treatment with the drug.

Intensive Protocol Improves Survival for Adults with Acute Lymphoblastic Leukemia

Intensive Protocol Improves Survival for Adults with Acute Lymphoblastic Leukemia

Event-free survival for adult patients with ALL has improved from 40% to 73% with the implementation of the NOPHO ALL 2008 protocol in July 2008.

Adjuvant Chemotherapy Improves Overall Survival in Early Stage NSCLC

Adjuvant chemotherapy in patients with stage Ib non-small cell lung cancer improved overall survival and 5-year overall survival.

Number of Ovarian Cancer Cases Not Treated Surgically or Not Treated at All Is Increasing

Number of Ovarian Cancer Cases Not Treated Surgically or Not Treated at All Is Increasing

The number of patients older than 75 years who do not undergo surgery is increasing, especially among those with stage III or IV ovarian cancer. Approximately 50% do not undergo surgery and 25% receive no treatment at all.

New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases

New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases

Researchers demonstrate how breast cancer cells invade bone marrow, where they escape chemotherapy and hormonal therapies that would otherwise eliminate the cancer cells.

Metastatic Ability May Precede Tumor Formation in Pancreatic Cancer

Metastatic Ability May Precede Tumor Formation in Pancreatic Cancer

Metastatic capabilities of pancreatic cancer might arise before tumors even form. Metastasis and advanced stage of disease at diagnosis are attributed to low survival rates for pancreatic cancer.

Carfilzomib Increases Survival for Patients With Relapsed Multiple Myeloma

Carfilzomib Increases Survival for Patients With Relapsed Multiple Myeloma

A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.

Biochemical Marker Is a Better Predictor of Adverse Effects in Patients with Non-small Cell Lung Cancer

Albumin concentration with an established cutoff point is proven a better predictor of both chemotherapy toxicity and survival in patients with advanced lung cancer.

CDC: Cigarette Smoking Drops in U.S. Adolescents

CDC: Cigarette Smoking Drops in U.S. Adolescents

A decreasing number of adolescents are smoking, but e-cigarette use and rates of distracted driving are on the rise for this group.

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.

Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication

Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication

Physical exercise may have a direct effect on cancer that is as effective as drugs for treating patients with prostate cancer, even for those with advanced stages of the disease.

ASCO: Aggressive Treatment Common in Terminal Cancer Patients

ASCO: Aggressive Treatment Common in Terminal Cancer Patients

Three in four of young or middle-aged patients with terminal cancer receive aggressive therapies in their last months of life.

Pembrolizumab Demonstrates Long-Term Survival in Advanced Melanoma

Pembrolizumab Demonstrates Long-Term Survival in Advanced Melanoma

At 3 years, 40% of patients with advanced melanoma treated with pembrolizumab are alive regardless of whether they had been treated with ipilimumab or not, follow-up results from the KEYNOTE-001 study reported at the ASCO 2016 Annual Meeting.

Dabrafenib Plus Trametinib Continue to Show Survival Benefit in BRAF-mutant Metastatic Melanoma

Dabrafenib Plus Trametinib Continue to Show Survival Benefit in BRAF-mutant Metastatic Melanoma

The longest overall survival follow-up among randomized phase 3 trials evaluating BRAF and MEK inhibitors in patients with BRAF-mutant metastatic melanoma to date has shown the best 3-year outcome with dabrafenib plus trametinib to be in patients with normal LDH and fewer than 3 disease sites, according to a presentation at the ASCO 2016 Annual Meeting.

Potential Survival Advantage Observed for 177Lu-Dotatate in Midgut Neuroendocrine Tumors

Potential Survival Advantage Observed for 177Lu-Dotatate in Midgut Neuroendocrine Tumors

NETTER-1 trial results of the somatostatin analogue peptide, 177Lu-DOTA0-Tyr3-octreotate (177Lu-Dotatate), suggest a potential survival benefit in patients with advanced midgut neuroendocrine tumors (NETs), attendees at the ASCO 2016 Annual Meeting were told.

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Greatest survival benefit observed for those taking the drug before their cancer diagnosis.

Tailored Dose-Dense Chemotherapy Improves Event-free Survival in High-Risk Breast Cancer

Tailored Dose-Dense Chemotherapy Improves Event-free Survival in High-Risk Breast Cancer

Tailored dose-dense chemotherapy significantly improved event-free survival and also showed efficacy in relapse-free and overall survival compared with standard adjuvant chemotherapy in patients with high-risk breast cancer, according to results of the phase 3 PANTHER study reported at the 2016 ASCO Annual Meeting.

Meta-analysis Confirms Lenalidomide Maintenance Prolongs Overall Survival in Multiple Myeloma

Meta-analysis Confirms Lenalidomide Maintenance Prolongs Overall Survival in Multiple Myeloma

Lenalidomide maintenance after high-dose melphalan and autologous stem cell transplant (ASCT) significantly prolonged overall survival in patients with multiple myeloma compared with no maintenance, a meta-analysis of 3 randomized controlled trials presented at the 2016 ASCO Annual Meeting has found.

Early Palliative Care Improves Quality of Life for Family Caregivers of Patients With Cancer

Early Palliative Care Improves Quality of Life for Family Caregivers of Patients With Cancer

The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.

Precision Medicine Linked to Better Outcomes in Early Trials

Precision Medicine Linked to Better Outcomes in Early Trials

Patients whose treatment was based on the molecular characteristics of their particular tumor had significantly better outcomes compared with patients who did not.

Pembrolizumab Improves Long-term Survival in Advanced Melanoma

Pembrolizumab Improves Long-term Survival in Advanced Melanoma

Four in 10 patients with newly diagnosed and previously treated advanced melanoma were alive 3 years after initiating pembrolizumab.

Vessel-Sparing Radiation Successfully Treats Prostate Cancer, Maintains Quality of Life

Radiation therapy delivered to the critical vessels surrounding the prostate can result in erectile dysfunction and bladder and renal irritation. Vessel-sparing radiation and an improved understanding of the anatomy of the prostate can reduce these effects.

Including Quality Measures In Treatment Regimens Increases Survival in Stage IIIA Non-Small Cell Lung Cancer

Including Quality Measures In Treatment Regimens Increases Survival in Stage IIIA Non-Small Cell Lung Cancer

When more quality measures are incorporated into patient care, survival rates for patients with stage IIIA non-small cell lung cancer (NSCLC) increase, but only 13% of eligible patients actually receive all 4 recommended quality measures.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs